Evidence map›Paper›PMID 37176091›Full record

ReviewInternational journal of molecular sciences2023

Applications of the Whole-Cell System in the Efficient Biosynthesis of Heme.

Hongfei Su, Xiaolin Chen, Shijing Chen, Mingzhang Guo, Huilin Liu

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. A novel P450 enzyme assay utilizing an NADPBiotechnology letters · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. High-level expression of leghemoglobin inFrontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hongfei SuSchool of Food and Health, Beijing Technology and Business University, Beijing 100048, China.
Xiaolin ChenSchool of Food and Health, Beijing Technology and Business University, Beijing 100048, China.
Shijing ChenSchool of Food and Health, Beijing Technology and Business University, Beijing 100048, China.
Mingzhang GuoSchool of Food and Health, Beijing Technology and Business University, Beijing 100048, China.ORCID 0000-0003-4846-9185
Huilin LiuSchool of Food and Health, Beijing Technology and Business University, Beijing 100048, China.ORCID 0000-0002-7912-2611

Funding

Cultivation Project of Double First-Class Disciplines of Food Science and Engineering, Beijing Technology & Business University BTBUYXTD202204Discipline Construction-Food Science and Engineering SPKX-202205Initial Scientific Research Fund for Young Teachers of Beijing Technology and Business University QNJJ2021-04
6 · The paper itself

Abstract

Heme has a variety of functions, from electronic reactions to binding gases, which makes it useful in medical treatments, dietary supplements, and food processing. In recent years, whole-cell system-based heme biosynthesis methods have been continuously explored and optimized as an alternative to the low-yield, lasting, and adverse ecological environment of chemical synthesis methods. This method relies on two biosynthetic pathways of microbial precursor 5-aminolevulinic acid (C4, C5) and three known downstream biosynthetic pathways of heme. This paper reviews the genetic and metabolic engineering strategies for heme production in recent years by optimizing culture conditions and techniques from different microorganisms. Specifically, we summarized and analyzed the possibility of using biosensors to explore new strategies for the biosynthesis of heme from the perspective of synthetic biology, providing a new direction for future exploration.

Indexed as

Biosynthetic PathwaysHemeAminolevulinic AcidMetabolic EngineeringSynthetic BiologyAminolevulinic AcidHemecell biosensorhememetabolic engineeringsynthetic biologywhole-cell manufacturing

Identifiers

PMID37176091
PMCPMC10179345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.